Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Brunel

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
American Journal of Infection Control|May 3, 2011
Measurement of hand hygiene compliance and gloving practices in different settings for the elderly considering the location of hand hygiene opportunities during patient careMatthieu Eveillard, Marie-Thérèse Pradelle, Bernadette Lefrancq, et al.
Atherosclerosis|November 3, 2015
Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUSRishi Puri, Steven E Nissen, Venu Menon, et al.
Diabetes, Obesity & Metabolism|July 11, 2018
N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular riskNienke M A Idzerda, Frederik Persson, Michelle J Pena, et al.
The Lancet. Diabetes & Endocrinology|January 18, 2016
Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trialHiddo J L Heerspink, Frederik Persson, Barry M Brenner, et al.
European Heart Journal|July 19, 2015
Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trialPardeep S Jhund, John J V McMurray, Nish Chaturvedi, et al.
JAMA|September 4, 2013
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialStephen J Nicholls, George L Bakris, John J P Kastelein, et al.
The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
American Journal of Infection Control|May 3, 2011
Measurement of hand hygiene compliance and gloving practices in different settings for the elderly considering the location of hand hygiene opportunities during patient careMatthieu Eveillard, Marie-Thérèse Pradelle, Bernadette Lefrancq, et al.
Atherosclerosis|November 3, 2015
Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUSRishi Puri, Steven E Nissen, Venu Menon, et al.
Diabetes, Obesity & Metabolism|July 11, 2018
N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular riskNienke M A Idzerda, Frederik Persson, Michelle J Pena, et al.
The Lancet. Diabetes & Endocrinology|January 18, 2016
Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trialHiddo J L Heerspink, Frederik Persson, Barry M Brenner, et al.
European Heart Journal|July 19, 2015
Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trialPardeep S Jhund, John J V McMurray, Nish Chaturvedi, et al.
JAMA|September 4, 2013
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialStephen J Nicholls, George L Bakris, John J P Kastelein, et al.
The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
Pageof 3